JAN 28, 2015 08:00 AM PST
Automated 3D Cell Culture and Screening by Imaging and Flow Cytometry
SPONSORED BY: Beckman Coulter Life Sciences
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE
5 90

Speakers:
  • Application Director 3D Biomatrix, Inc.
  • Staff Applications Scientist, Beckman Coulter Life Sciences
    Biography
      Mike Kowalski is a Staff Applications Scientist in the Sample Preparation and Applied Markets group of Beckman Coulter Life Sciences. He received his Ph.D. in Microbiology and Molecular Genetics from Harvard University. Prior to joining Beckman, Mike was a postdoctoral fellow at the Novartis Institutes for Biomedical Research, where he used automation to screen for novel regulators of stem cell pluripotency and differentiation. Since joining Beckman, Mike has developed automated applications in the areas of cell culture, cellular analysis, and mass spectrometry.

    Abstract:
    Drug developers are rapidly adopting three-dimensional (3D) cell cultures for drug screening since they provide a more physiologically relevant environment than two-dimensional cell cultures to screen compounds. Spheroids are a simple and well characterized, in vitro tumor model system. However, manual manipulations of these spheroid cultures can be laborious and challenges are amplified as sample throughput increases. This webinar, co-presented by 3D Biomatrix and Beckman Coulter, discussed automation of 3D cell culture for screening by imaging and flow cytometry.

    Learning Objectives:
    • Understand why drug developers are rapidly adopting three-dimensional (3D) cell cultures for drug screening
    • Learn about automation of 3D cell culture for screening by imaging and flow cytometry

    Show Resources
    Loading Comments...